(Q47591379)

4 February 2018

meta-analysis

0 references

title

Impact of locoregional treatment on the early-stage breast cancer patients: a retrospective analysis (English)

1 reference

4 February 2018

1 reference

J A van der Hage

1

1 reference

4 February 2018

H Putter

2

1 reference

4 February 2018

J Bonnema

3

1 reference

4 February 2018

H Bartelink

4

1 reference

4 February 2018

P Therasse

5

1 reference

4 February 2018

C J H van de Velde

6

1 reference

4 February 2018

EORTC Breast Cancer Group

7

1 reference

4 February 2018

publication date

1 October 2003

1 reference

4 February 2018

European Journal of Cancer

published in

1 reference

4 February 2018

volume

39

1 reference

4 February 2018

issue

15

1 reference

4 February 2018

page(s)

2192-2199

1 reference

4 February 2018

Effects of radiotherapy and surgery in early breast cancer. An overview of the randomized trials

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2803%2900572-0

7 January 2021

Significance of ipsilateral breast tumour recurrence after lumpectomy

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2803%2900572-0

7 January 2021

Long-term results of a randomized trial comparing breast-conserving therapy with mastectomy: European Organization for Research and Treatment of Cancer 10801 trial

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2803%2900572-0

7 January 2021

Reanalysis and results after 12 years of follow-up in a randomized clinical trial comparing total mastectomy with lumpectomy with or without irradiation in the treatment of breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2803%2900572-0

7 January 2021

Postoperative radiotherapy in high-risk premenopausal women with breast cancer who receive adjuvant chemotherapy. Danish Breast Cancer Cooperative Group 82b Trial.

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2803%2900572-0

7 January 2021

Postoperative radiotherapy in high-risk postmenopausal breast-cancer patients given adjuvant tamoxifen: Danish Breast Cancer Cooperative Group DBCG 82c randomised trial.

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2803%2900572-0

7 January 2021

Adjuvant radiotherapy and chemotherapy in node-positive premenopausal women with breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2803%2900572-0

7 January 2021

Does locoregional radiation therapy improve survival in breast cancer? A meta-analysis

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2803%2900572-0

7 January 2021

Improved survival after one course of perioperative chemotherapy in early breast cancer patients. long-term results from the European Organization for Research and Treatment of Cancer (EORTC) Trial 10854.

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2803%2900572-0

7 January 2021

Preoperative chemotherapy in primary operable breast cancer: results from the European Organization for Research and Treatment of Cancer trial 10902.

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2803%2900572-0

7 January 2021

Outcome at 8 years after breast-conserving surgery and radiation therapy for invasive breast cancer: influence of margin status and systemic therapy on local recurrence.

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2803%2900572-0

7 January 2021

The influence of pathologic tumor characteristics on locoregional recurrence rates following mastectomy

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2803%2900572-0

7 January 2021

Histological determinants for different types of local recurrence after breast-conserving therapy of invasive breast cancer. Dutch Study Group on local Recurrence after Breast Conservation (BORST)

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2803%2900572-0

7 January 2021

The influence of age and extensive intraductal component histology upon breast lumpectomy margin assessment as a predictor of residual tumor

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2803%2900572-0

7 January 2021

Factors influencing the effect of age on prognosis in breast cancer: population based study

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2803%2900572-0

7 January 2021

The influence of young age on outcome in early stage breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2803%2900572-0

7 January 2021

Local recurrence after breast-conserving therapy for invasive breast cancer: high incidence in young patients and association with poor survival.

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2803%2900572-0

7 January 2021

High local recurrence risk after breast-conserving therapy in node-negative premenopausal breast cancer patients is greatly reduced by one course of perioperative chemotherapy: A European Organization for Research and Treatment of Cancer Breast Canc

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2803%2900572-0

7 January 2021

Recurrence rates after treatment of breast cancer with standard radiotherapy with or without additional radiation

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2803%2900572-0

7 January 2021

The European Organization for Research and Treatment of Cancer (EORTC) Breast Cancer Group: quality control of surgical trials.

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2803%2900572-0

7 January 2021

Prognosis after treatment for loco-regional recurrence after mastectomy or breast conserving therapy in two randomised trials (EORTC 10801 and DBCG-82TM). EORTC Breast Cancer Cooperative Group and the Danish Breast Cancer Cooperative Group.

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2803%2900572-0

7 January 2021

Ipsilateral breast tumor recurrence as a predictor of distant disease: implications for systemic therapy at the time of local relapse

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2803%2900572-0

7 January 2021

Local recurrences and distant metastases after conservative breast cancer treatments: partly independent events.

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2803%2900572-0

7 January 2021

Local recurrence after breast-conserving surgery and radiotherapy. Frequency, time course, and prognosis

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2803%2900572-0

7 January 2021

Breast-conserving therapy: proteases as risk factors in relation to survival after local relapse

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2803%2900572-0

7 January 2021

The link between local recurrence and distant metastases in human breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2803%2900572-0

7 January 2021

Local recurrence after breast conservation therapy for early stage breast carcinoma: detection, treatment, and outcome in 266 patients. Dutch Study Group on Local Recurrence after Breast Conservation (BORST).

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2803%2900572-0

7 January 2021

The prognostic significance of late local recurrence after breast-conserving therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2803%2900572-0

7 January 2021

Role of isolated locoregional recurrence of breast cancer: results of four prospective studies

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2803%2900572-0

7 January 2021

Ten-year results of a comparison of conservation with mastectomy in the treatment of stage I and II breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2803%2900572-0

7 January 2021

Local failure is responsible for the decrease in survival for patients with breast cancer treated with conservative surgery and postoperative radiotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2803%2900572-0

7 January 2021

The effects of type of surgery and time on psychological adjustment in women after breast cancer treatment.

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2803%2900572-0

7 January 2021

10.1016/S0959-8049(03)00572-0

Identifiers

DOI

1 reference

4 February 2018

1 reference

4 February 2018